HMG-CoA reductase inhibitors (statin) prevents retinal neovascularization in a model of oxygen-induced retinopathy.
about
Multi-modal proteomic analysis of retinal protein expression alterations in a rat model of diabetic retinopathyNADPH oxidase, NOX1, mediates vascular injury in ischemic retinopathy.Arginase 2 deletion reduces neuro-glial injury and improves retinal function in a model of retinopathy of prematurity.Erythropoietin receptor antibody inhibits oxidative stress induced retinal neovascularization in mice.Caspase-14: a novel caspase in the retina with a potential role in diabetic retinopathy.Lipid metabolites in the pathogenesis and treatment of neovascular eye disease.Diverse effects of statins on angiogenesis: new therapeutic avenues.Statins for prevention of diabetic-related blindness: a new treatment option?HIF-1α siRNA reduces retinal neovascularization in a mouse model of retinopathy of prematurity.Activation of the endothelin system mediates pathological angiogenesis during ischemic retinopathy.Therapeutic Effects of a Novel Agonist of Peroxisome Proliferator-Activated Receptor Alpha for the Treatment of Diabetic Retinopathy.Atorvastatin inhibits RhoC function and limits head and neck cancer metastasis.STAT3-mediated activation of miR-21 is involved in down-regulation of TIMP3 and neovascularization in the ischemic retina.Oral Monomethyl Fumarate Therapy Ameliorates Retinopathy in a Humanized Mouse Model of Sickle Cell Disease.Angiotensin II type 1 receptor antagonist prevents hepatic carcinoma in rats with nonalcoholic steatohepatitis.Subfoveal choroidal thickness in multiple evanescent white dot syndrome.Hydrogen saline treatment attenuates hyperoxia-induced retinopathy by inhibition of oxidative stress and reduction of VEGF expression.Statins in rhegmatogenous retinal detachment are associated with low intravitreal angiopoietin-2, VEGF and MMP-2 levels, and improved visual acuity gain in vitrectomized patients
P2860
Q28476732-63DE7181-CF44-41CF-B316-43C1D5CA0613Q33632781-2D878580-7446-47BF-BAC6-15A06BE39855Q33979991-81DD0C9A-321A-46A9-AFDF-261370BF6047Q35924178-8971B355-21DD-4F2E-B17F-73A17EEF3FF2Q36145936-5BDDE984-6A60-4134-8974-5B223D36D480Q37011339-1CFFDA4C-F6F2-4DB7-AF42-1E413AAF24E6Q37680944-22B7B199-8DA3-4726-83D8-68E049D0FC36Q38506903-F8D047FD-6A27-4D43-A477-4C8308E8089EQ40033199-7F131797-6A11-49A0-A99F-E2FDC631FB97Q42214765-0EC611BC-08CE-4FB9-A555-2F52F038ADB2Q42373000-C49C7DA3-1C6D-49CE-BE9F-AE9029864E0CQ43111820-CFE8D3DE-FC0D-49E8-9DEA-5A9D6737877AQ47143565-1248E4C9-093F-44C2-BED8-C3E159B6197CQ47160705-0AFEED83-4A5D-4BA2-A7E7-DAF536542F06Q47272307-774984B6-4D27-474E-BC7A-4CC8418CFE14Q50509368-4E7C5EB6-7217-46DD-B896-3A14330EE6DFQ54334741-AD4156DF-6058-4D96-BDF1-A58000C96B48Q58075251-711B66A5-F60D-46EF-AB4C-6BB67D42C816
P2860
HMG-CoA reductase inhibitors (statin) prevents retinal neovascularization in a model of oxygen-induced retinopathy.
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
HMG-CoA reductase inhibitors ( ...... of oxygen-induced retinopathy.
@ast
HMG-CoA reductase inhibitors ( ...... of oxygen-induced retinopathy.
@en
type
label
HMG-CoA reductase inhibitors ( ...... of oxygen-induced retinopathy.
@ast
HMG-CoA reductase inhibitors ( ...... of oxygen-induced retinopathy.
@en
prefLabel
HMG-CoA reductase inhibitors ( ...... of oxygen-induced retinopathy.
@ast
HMG-CoA reductase inhibitors ( ...... of oxygen-induced retinopathy.
@en
P2093
P2860
P356
P1476
HMG-CoA reductase inhibitors ( ...... of oxygen-induced retinopathy
@en
P2093
Azza B El-Remessy
Dennis M Marcus
M Ali Behzadian
Manuela Bartoli
Mohamed Istanboli
Mohamed Labazi
Robert W Caldwell
Ruth B Caldwell
P2860
P304
P356
10.1167/IOVS.08-2158
P407
P577
2008-12-20T00:00:00Z